The Indonesian Food and Drug Authority (BPOM) has expressed its support for strengthening the local pharmaceutical industry with the aim of reducing reliance on imports that reach up to 80%. This statement was made during the inauguration of a new factory in Pasuruan, where the Deputy Head of the Authority, William Adi Tiga, emphasized that the heavy dependence on imports poses a significant challenge to the national industry.
Tiga pointed out that approximately 70-80% of the raw materials used in drug production in Indonesia come from abroad, despite the fact that 80% of the country's pharmaceutical needs are met by local companies. This reliance on imports hinders the progress of the chemical and pharmaceutical sectors in the country.
Event Details
During the opening of the fourth production line of Satoria Pharma, Tiga clarified that there is an urgent need to enhance independence in the production of raw materials. He noted that developing the pharmaceutical salt industry in Indonesia could be a significant step in this direction, as these materials are essential for producing intravenous fluids.
Currently, there are four companies engaged in the production of pharmaceutical salt, three of which are located in East Java, capable of producing around 4000 tons annually, which is sufficient to meet the local market's needs estimated at around 1500 to 1700 tons annually by 2025.
Background & Context
Historically, Indonesia has faced significant challenges in the pharmaceutical industry, heavily relying on imports to meet its needs. However, the Indonesian government has been striving for years to bolster local production by providing support to local companies and developing the necessary infrastructure.
These steps are part of a comprehensive strategy aimed at achieving self-sufficiency across various sectors, including the health sector, which is considered a national priority.
Impact & Consequences
These initiatives represent a positive step towards enhancing Indonesia's economic independence, as they could lead to narrowing the trade balance gap by reducing reliance on imports. Moreover, strengthening the local pharmaceutical industry could contribute to creating new job opportunities and stimulating the local economy.
Furthermore, increasing the production capacity of local companies, such as Satoria, which aims to produce 230 million bottles of intravenous fluids annually, demonstrates the private sector's commitment to contributing to the government's goals.
Regional Significance
Indonesia's experience in strengthening its pharmaceutical industry serves as a model for Arab countries, which face similar challenges regarding reliance on imports. Arab nations can benefit from this experience by enhancing their production capabilities in the health and pharmaceutical sectors.
In conclusion, strengthening the local pharmaceutical industry in Indonesia highlights the importance of economic independence, a lesson that could benefit Arab countries in their pursuit of self-sufficiency across various fields.